Search research articles
Contact Us
Filters
Showing results (21-30 of 162) with videos related to
Page
of 17
Sort By:
British Journal of Haematology
|
March 8, 2016
Present and future of molecular monitoring in chronic myeloid leukaemia
Simona Soverini, Caterina De Benedittis, Manuela Mancini, et al.
Pharmacological Research
|
February 11, 2018
Impact of SLC22A1 and CYP3A5 genotypes on imatinib response in chronic myeloid leukemia: A systematic review and meta-analysis
Sarah Cargnin, Gloria Ravegnini, Simona Soverini, et al.
Hemasphere
|
March 21, 2022
Current treatment approaches in CML
Fausto Castagnetti, Gabriele Gugliotta, Simona Soverini, et al.
The Oncologist
|
June 3, 2011
Choosing the best second-line tyrosine kinase inhibitor in imatinib-resistant chronic myeloid leukemia patients harboring Bcr-Abl kinase domain mutations: how reliable is the IC₅₀?
Simona Soverini, Gianantonio Rosti, Ilaria Iacobucci, et al.
Molecular Cancer
|
February 20, 2018
Chronic myeloid leukemia: the paradigm of targeting oncogenic tyrosine kinase signaling and counteracting resistance for successful cancer therapy
Simona Soverini, Manuela Mancini, Luana Bavaro, et al.
Pharmacogenomics
|
August 28, 2012
Advances in treatment of chronic myeloid leukemia with tyrosine kinase inhibitors: the evolving role of Bcr-Abl mutations and mutational analysis
Simona Soverini, Giovanni Martinelli, Gianantonio Rosti, et al.
Haematologica
|
April 12, 2005
New tyrosine kinase inhibitors in chronic myeloid leukemia
Giovanni Martinelli, Simona Soverini, Gianantonio Rosti, et al.
Best Practice & Research. Clinical Haematology
|
December 5, 2009
Response definitions and European Leukemianet Management recommendations
Michele Baccarani, Fausto Castagnetti, Gabriele Gugliotta, et al.
Journal of Clinical Medicine
|
June 6, 2020
Chronic Myeloid Leukemia Prognosis and Therapy: Criticisms and Perspectives
Domenico Russo, José Valentín Garcia-Gutierrez, Simona Soverini, et al.
International Journal of Molecular Sciences
|
July 2, 2021
Targeting Leukemic Stem Cells in Chronic Myeloid Leukemia: Is It Worth the Effort?
Simona Soverini, Sara De Santis, Cecilia Monaldi, et al.
Page
of 17
Search research articles
Search
Showing results (21-30 of 162) with videos related to
Sort By:
Page
of 17
British Journal of Haematology
|
March 8, 2016
Present and future of molecular monitoring in chronic myeloid leukaemia
Simona Soverini, Caterina De Benedittis, Manuela Mancini, et al.
Pharmacological Research
|
February 11, 2018
Impact of SLC22A1 and CYP3A5 genotypes on imatinib response in chronic myeloid leukemia: A systematic review and meta-analysis
Sarah Cargnin, Gloria Ravegnini, Simona Soverini, et al.
Hemasphere
|
March 21, 2022
Current treatment approaches in CML
Fausto Castagnetti, Gabriele Gugliotta, Simona Soverini, et al.
The Oncologist
|
June 3, 2011
Choosing the best second-line tyrosine kinase inhibitor in imatinib-resistant chronic myeloid leukemia patients harboring Bcr-Abl kinase domain mutations: how reliable is the IC₅₀?
Simona Soverini, Gianantonio Rosti, Ilaria Iacobucci, et al.
Molecular Cancer
|
February 20, 2018
Chronic myeloid leukemia: the paradigm of targeting oncogenic tyrosine kinase signaling and counteracting resistance for successful cancer therapy
Simona Soverini, Manuela Mancini, Luana Bavaro, et al.
Pharmacogenomics
|
August 28, 2012
Advances in treatment of chronic myeloid leukemia with tyrosine kinase inhibitors: the evolving role of Bcr-Abl mutations and mutational analysis
Simona Soverini, Giovanni Martinelli, Gianantonio Rosti, et al.
Haematologica
|
April 12, 2005
New tyrosine kinase inhibitors in chronic myeloid leukemia
Giovanni Martinelli, Simona Soverini, Gianantonio Rosti, et al.
Best Practice & Research. Clinical Haematology
|
December 5, 2009
Response definitions and European Leukemianet Management recommendations
Michele Baccarani, Fausto Castagnetti, Gabriele Gugliotta, et al.
Journal of Clinical Medicine
|
June 6, 2020
Chronic Myeloid Leukemia Prognosis and Therapy: Criticisms and Perspectives
Domenico Russo, José Valentín Garcia-Gutierrez, Simona Soverini, et al.
International Journal of Molecular Sciences
|
July 2, 2021
Targeting Leukemic Stem Cells in Chronic Myeloid Leukemia: Is It Worth the Effort?
Simona Soverini, Sara De Santis, Cecilia Monaldi, et al.
Page
of 17